Sun Pharmaceutical Industries reported a consolidated net loss of Rs 2,277.25 crore in Q4 FY22 as against a net profit of Rs 894.15 crore in Q4 FY21.
Hong Kong share market finished session at six-week high on Monday, 30 May 2022, as appetite for risk assets underpinned on tracking positive lead from Wall Street last Friday on easing concerns over excessive U.S. inflation. Meanwhile positive trade on the Mainland A-share market on Chinas easing of COVID-19 mobility restrictions also boosted sentiment. Hong Kong stocks also received a boost after an agreement to […]
The total cost of acquisition is Rs6.77 crore.
The Mainland China market finished session higher on Wednesday, 25 May 2022, on economic growth optimism as Shanghai inched closer to a planned end to a two-month coronavirus lockdown set for Wednesday. At close of trade, the benchmark Shanghai Composite Index increased by 0.6%, or 18.82 points, to 3,149.06. The Shenzhen Composite Index, which tracks stocks on Chinas second exchange, added 1.07%, or 20.86 points, […]
Sales rise 0.45% to Rs 168.10 crore
Sales decline 8.33% to Rs 0.11 crore
Sales rise 265.48% to Rs 115.82 crore
Sales rise 17.16% to Rs 20.21 crore
Sales decline 11.95% to Rs 85.29 crore

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.